Inhalation Sciences ramps up popular expert webinar series with new release on May 2[nd], 2023

REG

ISAB is partnering with industry experts in two new webinars in its popular series. The latest webinar, on its unique in vitro module, the DissolvIt method, was extremely well-received, attracting 300 subscribers. It was co-presented by bioanalytic consultant Prof Hermann Mascher, together with ISAB's in vitro specialist and Director of Projects Dr. Maria Malmlöf. Watch the webinar HERE.

Webinar #2: May 2nd 2023

ISAB will present its next webinar, on in vivo studies, on May 2nd 2023 . It will be co-presented by an expert in the field - Matt Reed from Coelus Bio. Matt is a pharmacologist and a board-certified toxicologist with over 25 years' experience in which he has been a part of multiple successful R&D programs that that have transitioned to regulatory approval for small molecules, biologics, oligonucleotides

Register for the May 2nd webinar HERE

ISAB offers a competitive range of in vivo testing solutions, including its unique intratracheal module. The module uses a catheter connected to PreciseInhale that bypasses the nasal airways, ensuring test substances are retained in the lung and delivering high-precision data of, typically, <10% Standard Deviation.

Webinar #3 - customer partner

ISAB's third expert webinar is expected to be presented later in Fall 2023.

CEO Manoush Masarrat: "These webinars are a superb showcase of our unique expertise and capabilities. I would urge anyone in inhaled pharmaceutical development who is interested in de-risking their drug development early on to register and take part. Our inhalation research services (IRS) are an important key to growth for us, as we share our knowledge and capabilities we build partnerships, increase sales and accelerate our sales cycles."

Datum 2023-04-19, kl 10:34
Källa Cision
SAVR är investeringsplattformen som utmanar branschen och gör det både enklare och roligare att investera. Betala aldrig för mycket! Alla aktier och ETF:er från 1 kr, och få upp till 50 % rabatt på alla fonder. Automatiskt courtage och samma enkla prismodell på alla marknader.
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet